These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19258709)

  • 1. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
    Gos M; Leszkiewicz M; Abramowicz A
    Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
    Schubbert S; Bollag G; Shannon K
    Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular aspects of RAS related disorders.
    Denayer E; de Ravel T; Legius E
    J Med Genet; 2008 Nov; 45(11):695-703. PubMed ID: 18550698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis.
    Nyström AM; Ekvall S; Thuresson AC; Denayer E; Legius E; Kamali-Moghaddam M; Westermark B; Annerén G; Bondeson ML
    Eur J Med Genet; 2010; 53(3):117-21. PubMed ID: 20302979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
    Zenker M
    Horm Res; 2009 Dec; 72 Suppl 2():57-63. PubMed ID: 20029240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
    Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
    J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.
    Zenker M; Lehmann K; Schulz AL; Barth H; Hansmann D; Koenig R; Korinthenberg R; Kreiss-Nachtsheim M; Meinecke P; Morlot S; Mundlos S; Quante AS; Raskin S; Schnabel D; Wehner LE; Kratz CP; Horn D; Kutsche K
    J Med Genet; 2007 Feb; 44(2):131-5. PubMed ID: 17056636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactive Ras in developmental disorders and cancer.
    Schubbert S; Shannon K; Bollag G
    Nat Rev Cancer; 2007 Apr; 7(4):295-308. PubMed ID: 17384584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costello syndrome and related disorders.
    Quezada E; Gripp KW
    Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes.
    Lee BH; Kim JM; Jin HY; Kim GH; Choi JH; Yoo HW
    J Pediatr; 2011 Dec; 159(6):1029-35. PubMed ID: 21784453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy in Noonan syndrome and related disorders.
    Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
    Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.